Skip to main content
. 2018 May 1;9(33):23289–23305. doi: 10.18632/oncotarget.25289

Figure 6. Treatment with the anti-STn, S3F-CL-MMAE, on CD133 and STn populations in vitro.

Figure 6

OV90, OVCAR3 and OVCAR4 cell lines were harvested 72 (A) or 144 (B) hours post treatment with vehicle or S3F-CL-MMAE (10 nM), and the relative frequency of STn-/CD133-, STn+/CD133-, STn-/CD133+ and STn+/CD133+ fractions was determined by flow cytometry. Error bars represent the mean and SEM. *p < 0.05. All experiments were repeated four times.